Mason Street Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Mason Street Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-84,500	Closed	-$2.03M	–	1880
2014 Q4	$2.03M	Hold	84,500	–	–	0.01%	949
2014 Q3	$2.13M	Hold	84,500	–	–	0.02%	926
2014 Q2	$2.21M	Hold	84,500	–	–	0.02%	919
2014 Q1	$2.18M	Hold	84,500	–	–	0.02%	910
2013 Q4	$1.71M	Hold	84,500	–	–	0.01%	1005
2013 Q3	$2.21M	Buy	+84,500	New	+$2.12M	0.03%	665

Other funds holding HPTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mason Street Advisors's HPTX Position: Q1 2015 in Review

Mason Street Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 84,500 shares — an estimated $2.03M sold.

Mason Street Advisors first reported a position in HPTX in Q3 2013 and held it in 6 quarters. The position peaked at $2.21M in Q3 2013. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

Mason Street Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 84,500 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $2.03M.
Mason Street Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 6 quarters.
Mason Street Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.21M in Q3 2013.
134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.